From: Exploring molecular targets: herbal isolates in cervical cancer therapy
Name | Degree | Betweenness | Closeness |
---|---|---|---|
CDK1 | 171 | 0.051 | 0.440 |
CCNA2 | 151 | 0.024 | 0.426 |
CCNB1 | 145 | 0.025 | 0.423 |
TP53 | 144 | 0.153 | 0.482 |
TOP2A | 143 | 0.021 | 0.423 |
BUB1 | 143 | 0.010 | 0.405 |
NCAPG | 138 | 0.010 | 0.381 |
BUB1B | 127 | 0.010 | 0.404 |
AURKB | 125 | 0.009 | 0.402 |
CDC6 | 122 | 0.009 | 0.390 |
RRM2 | 122 | 0.008 | 0.403 |
CDC20 | 119 | 0.007 | 0.387 |
ASPM | 118 | 0.006 | 0.374 |
NDC80 | 117 | 0.011 | 0.372 |
CHEK1 | 116 | 0.010 | 0.406 |
AURKA | 114 | 0.014 | 0.408 |
EXO1 | 114 | 0.010 | 0.398 |
RFC4 | 110 | 0.007 | 0.397 |
BIRC5 | 107 | 0.031 | 0.419 |
CENPF | 100 | 0.006 | 0.365 |
CEP55 | 97 | 0.007 | 0.366 |
PCNA | 95 | 0.015 | 0.394 |
RAD51 | 94 | 0.013 | 0.396 |
MCM5 | 93 | 0.010 | 0.384 |
TYMS | 91 | 0.009 | 0.369 |
STAT3 | 90 | 0.038 | 0.434 |
EGFR | 89 | 0.085 | 0.447 |
MKI67 | 89 | 0.007 | 0.398 |
AKT1 | 86 | 0.050 | 0.446 |
HMMR | 83 | 0.013 | 0.389 |
FOXM1 | 81 | 0.007 | 0.396 |
CTNNB1 | 75 | 0.037 | 0.431 |
MYC | 73 | 0.025 | 0.437 |
RFC3 | 71 | 0.008 | 0.381 |
MAPK3 | 68 | 0.033 | 0.427 |
IL6 | 62 | 0.022 | 0.392 |
CCND1 | 62 | 0.016 | 0.430 |
ACTB | 61 | 0.044 | 0.438 |
HRAS | 61 | 0.022 | 0.395 |
CDC25C | 61 | 0.007 | 0.396 |
ESR1 | 58 | 0.025 | 0.419 |
TNF | 58 | 0.023 | 0.393 |
VEGFA | 57 | 0.011 | 0.395 |
RPA3 | 57 | 0.008 | 0.373 |
STAT1 | 55 | 0.030 | 0.401 |
JUN | 55 | 0.019 | 0.421 |
PIK3CA | 55 | 0.014 | 0.391 |
ERBB2 | 53 | 0.025 | 0.423 |
PTEN | 52 | 0.019 | 0.413 |
CASP3 | 52 | 0.017 | 0.429 |
MAPK1 | 52 | 0.010 | 0.396 |
CDH1 | 50 | 0.014 | 0.396 |
CD44 | 49 | 0.023 | 0.407 |
HIF1A | 47 | 0.013 | 0.417 |
E2F1 | 47 | 0.012 | 0.396 |
MDM2 | 46 | 0.013 | 0.411 |
CDKN2A | 46 | 0.010 | 0.403 |